Abstract
Persons with primary brain tumour can suffer from depression. Depression may hinder rehabilitation intervention leading to further deterioration of patient's health and functioning. The Cochrane Review aimed to assess the effectiveness and adverse effects of pharmacological treatment of depression in people with a primary brain tumour. A Cochrane Review by Beevers et al. was summarized with comments. The review did not find any eligible studies from the 2090 studies screened which included randomized controlled trials, cohort studies and case-control studies. There is no high-quality evidence as to whether pharmacological treatments for depression in people with primary brain tumours are either effective or harmful.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
